Go Pro

Hikma Pharmaceuticals (HKMPY) News Today

Hikma Pharmaceuticals logo
$43.88 0.00 (0.00%)
As of 08/25/2026 09:30 AM Eastern

Hikma Pharmaceuticals Latest News

Hikma Pharmaceuticals PLC ADR HKMPY
Hikma Pharmaceuticals advances Tuesday, outperforms market
Barclays Keeps Their Hold Rating on Hikma Pharmaceuticals (HIK)
Hikma Pharmaceuticals (HIK) Gets a Buy from J.P. Morgan
Hikma Pharmaceuticals climbs Tuesday, outperforms market
2 overlooked UK shares to consider for dividend income
Hikma Pharmaceuticals (HIK) Gets a Hold from Barclays
Hikma Pharmaceuticals (HIK) Receives a Buy from Berenberg Bank
Axsome Therapeutics settles Sunosi patent litigation with Hikma

Hikma Pharmaceuticals Media Mentions By Week

Hikma Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HKMPY
News Sentiment

0.00

0.87

Average
Healthcare
News Sentiment

Hikma Pharmaceuticals News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HKMPY Articles
This Week

0

0

HKMPY Articles
Average Week

Hikma Pharmaceuticals Trends on MarketBeat

This week vs. last week
Page Views
102
+34%
Get Hikma Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for HKMPY and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Hikma Pharmaceuticals dated 8/15/2026.
From Our Partners